- GSK’s India unit posts 9% rise in Q3 profit as input costs slump Reuters.com
- GlaxoSmithKline Pharmaceuticals net profit rises 9.45% to Rs 165 cr in Q3 Business Standard
- GSKs India unit Q3 profit up 9% as input costs slump, op revenue fell 1.7% Business Standard
- View Full Coverage on Google News
Source link